Home » Topics » BioWorld Science

BioWorld Science
RSS

Enrollment begins in phase II study of Stemedica's itMSCs in patients with COVID-19

Aug. 6, 2021

Aptahem reports positive preliminary results from GLP studies of Apta-1

Aug. 6, 2021

New thyroid hormone receptor agonists divulged by Eccogene

Aug. 6, 2021

Hisun Accuray Therapeutics, Zhejiang Hisun Pharmaceutical present SHP-2 inhibitors

Aug. 6, 2021

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent cereblon ligands

Aug. 6, 2021

Suzhou Zelgen Biosciences discovers G12C mutant GTPase KRAS inhibitors

Aug. 6, 2021

Enanta nominates EDP-235 as clinical candidate for the treatment of COVID-19

Aug. 6, 2021

Syros enters clinical supply agreement with Roche to evaluate SY-5609 as part of INTRINSIC study

Aug. 6, 2021

Positive phase II data published from GENETIC-AF study of bucindolol in patients with heart failure

Aug. 6, 2021

KIR3DL3-HHLA2 pathway could be targeted for cancer immunotherapy

Aug. 5, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...